Leap Therapeutics Inc. Stock
Price
Target price
€0.34
€0.34
4.350%
0.014
4.350%
€5.35
05.06.25 / Stuttgart Stock Exchange
WKN: A3EMJP / Symbol: LPTX / Name: Leap Therapeutics / Stock / Micro Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Loading data...
Your prediction
Leap Therapeutics Inc. Stock
A very strong showing by Leap Therapeutics Inc. today, with an increase of €0.014 (4.350%) compared to yesterday's price.
Our community is currently high on Leap Therapeutics Inc. with 3 Buy predictions and 0 Sell predictions.
Based on the current price of 0.34 € the target price of 5 € shows a potential of 1388.1% for Leap Therapeutics Inc. which would more than double the current price.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Leap Therapeutics Inc. stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Leap Therapeutics Inc. in the next few years
Pros
?
M***** P*******
?
G***** c******* t* c**********
?
C******** o* t** e**********
Cons
?
S********** s********
?
B****
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Comments
Leap Therapeutics, Inc. (NASDAQ: LPTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.50 price target on the stock.
Show more
Ratings data for LPTX provided by MarketBeat
Leap Therapeutics, Inc. (NASDAQ: LPTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.50 price target on the stock.
Show more
Ratings data for LPTX provided by MarketBeat
Leap Therapeutics, Inc. (NASDAQ: LPTX) is now covered by analysts at Rodman & Renshaw. They set a "buy" rating and a $8.00 price target on the stock.
Show more
Ratings data for LPTX provided by MarketBeat